Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antisecretory Factor During Concomitant and Adjuvant Therapy of Primary Glioblastoma, a Randomised, Prospective and Double Blinded Study

NCT05669820 is registered in ClinicalTrials.gov with Peter Siesjö as lead sponsor.

NCT NCT05669820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05669820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antisecretory Factor During Concomitant and Adjuvant Therapy of Primary Glioblastoma, a Randomised, Prospective and Double Blinded Study
Lead sponsor
Peter Siesjö
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 15, 2024
Completion date
December 1, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma